Exploratory Measurement Science
ID: 7Type: Phase I
Overview

Topic

Exploratory Measurement Science

Agency

Department of CommerceNational Institute of Standards and Technology

Program

Type: SBIRPhase: Phase IYear: 2024

Topic Link

https://www.sbir.gov/node/2474019

Additional Information

https://www.nist.gov/tpo/small-business-innovation-research-program-sbir
Timeline
    Description

    The Department of Commerce's National Institute of Standards and Technology (NIST) is seeking proposals for the NIST FY 2024 Small Business Innovation Research (SBIR) Phase I program. The specific topic of the solicitation is "Exploratory Measurement Science".

    This solicitation is focused on research in the field of measurement science and aims to support innovative projects that explore new measurement techniques, methods, or technologies. The goal is to advance the accuracy, reliability, and efficiency of measurements in various industries and applications.

    The potential impacts of the technology or research funded through this program include improved measurement capabilities, enhanced product quality, increased manufacturing efficiency, and better understanding of physical phenomena. The research outcomes can have broad applications across industries such as healthcare, manufacturing, energy, and environmental monitoring.

    The Phase I program provides funding for feasibility studies and proof-of-concept research. The project duration is typically six months, and successful Phase I awardees may be eligible for Phase II funding to further develop and commercialize their technology.

    Interested applicants can find more information and submit their proposals through the NIST SBIR program website. The solicitation is currently closed, and the application due date was December 22, 2023.

    For more details, please refer to the NIST FY 2024 Small Business Innovation Research (SBIR) Phase I NOFO document available at grants.gov.

    Files
    No associated files provided.
    Similar Opportunities
    NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) topic. This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: link.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: link.
    DOD STTR 24.D Annual - Optical-Atomic System Integration & Calibration (OASIC)
    Active
    Department of Defense
    The Department of Defense (DOD) is seeking proposals for the topic of "Optical-Atomic System Integration & Calibration (OASIC)" as part of the Small Business Innovation Research (SBIR) program. The objective is to create a user facility for an atom-based quantum testbed that can prototype, validate, and benchmark nanophotonic, optoelectronic, and electronic components and sub-systems. The goal is to enable the development of scalable, low-SWaP atom-based quantum sensors, clocks, computing architectures, and other integrated or chip-scale quantum technologies. The solicitation emphasizes the need for rigorous testing and evaluation procedures compatible with the performance requirements of atom-based quantum devices. The Phase I of the project will focus on designing and analyzing the performance and operation of the proposed testbed user facility, as well as developing an operation and business plan. The Phase II will involve constructing and demonstrating the quantum testbed based on the Phase I design. The project duration for Phase I is 4 months, and for Phase II is 24 months. The solicitation encourages the development of integrated, low-SWaP quantum systems for applications in defense and commercial markets. The deadline for proposal submission is March 31, 2025. For more information, visit the solicitation link.
    NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of unlicensed products, or administration of licensed products for unapproved indications. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, study management and oversight, safety monitoring, and regulatory activities. The project duration is not specified, but the solicitation is open until January 14, 2027. The funding specifics can be found on the grants.nih.gov website.
    SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to provide additional support for later stage research and development (R&D) and product development not typically supported through Phase II or Phase IIB grants or contracts. The program is designed to bridge the funding gap between the end of the SBIR/STTR Phase II award and the commercialization stage, often referred to as the "Valley of Death." The program supports projects that require technical assistance and R&D studies typically outsourced to contract research organizations (CROs), such as regulatory assistance, IND/IDE enabling studies, toxicology, manufacturing, and clinical trials. The program also supports activities important for commercialization, such as product development, market planning, market research, and costs related to license agreements and partnerships. The program is open to companies that have received Phase II or Phase IIB funding from NIH within the last 36 months. The application due dates are September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, and April 5, 2025. For more information and to apply, visit the solicitation agency URL: link.
    NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, safety monitoring, and regulatory activities. The project duration is not specified, but the application due dates are provided. More information can be found on the grants.gov website.
    Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Phase II applications, including Fast-Track applications. The application due date is March 13th of each year, starting in 2024. For more information, visit the solicitation link.
    DOD STTR 24.D Annual - Optical-Atomic System Integration & Calibration (OASIC)
    Active
    Department of Defense
    The Department of Defense (DOD) is seeking proposals for the topic of "Optical-Atomic System Integration & Calibration (OASIC)" as part of the Small Business Innovation Research (SBIR) program. The objective is to create a user facility for an atom-based quantum testbed that can prototype, validate, and benchmark nanophotonic, optoelectronic, and electronic components and sub-systems. The goal is to enable the development of scalable, low-SWaP atom-based quantum sensors, clocks, computing architectures, and other integrated or chip-scale quantum technologies. The solicitation emphasizes the need for rigorous testing and evaluation procedures compatible with the performance requirements of atom-based quantum devices. The Phase I of the project will involve designing and analyzing the performance and operation of the proposed quantum testbed user facility, as well as developing an operation and business plan. The Phase II will focus on constructing and demonstrating the quantum testbed based on the Phase I design. The project duration for Phase II is 24 months. The development of integrated, low-SWaP quantum systems has applications in defense, communications, logistics, exploration, pharmaceuticals, and scientific research. The solicitation encourages the facility to be located at an academic site with a commercial entity responsible for operation and management. The Phase II milestones include reports on component acquisition and fabrication, interim progress reports, and a final report describing the construction and benchmarking of the quantum testbed. The Phase III of the project involves the dual-use applications of the developed quantum systems in both defense and commercial sectors.
    SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to provide additional support for later stage research and development (R&D) and product development not typically supported through Phase II or Phase IIB grants or contracts. The program is designed to bridge the funding gap between the end of the SBIR/STTR Phase II award and the commercialization stage, often referred to as the "Valley of Death." The program supports new "Type 1" applications from recipients with Phase II or IIB SBIR/STTR awards that have been active within the last 36 months. The program focuses on providing technical assistance and late stage R&D activities, such as regulatory strategy development, intellectual property strategy development, manufacturing assistance, and market research. The program also supports activities related to late stage development, including replication of key studies, optimization of manufacturing processes, animal studies, and development of clinical trial supplies. The program allows for outsourcing of work to third-party technical assistance providers, but the small business should play a substantive role in the oversight and management of the R&D activities. The program does not support clinical trials and cannot be used to pay filing fees for patents or FDA submissions. The program is open for applications until April 6, 2025, and more information can be found on the grants.gov website.